Financing - May 26, 2026
Spago Nanomedical resolves on a rights issue of approximately SEK 16 million
The Board of Directors of Spago Nanomedical has resolved on a new issue of shares with preferential rights for the company’s existing shareholders of approximately SEK 16 million before issue costs.
Financing - May 22, 2026
Neobiomics receives investment from HealthCap
The company has announced an investment led by HealthCap, and conjunction with this capital infusion, Neobiomics strengthens its board with the appointment of a new director, Mårten Steen, Managing Partner at HealthCap.
Financing - May 5, 2026
IRLAB resolves on a rights issue of approx SEK 68 million
The Board of Directors of IRLAB Therapeutics has resolved on a rights issue of shares of series A corresponding to approximately SEK 68 million.
Biotech Business - April 16, 2026
EIB backs BioLamina with EUR 20 million
The European Investment Bank (EIB) is lending EUR 20 million to BioLamina to expand its development of laminin technologies.
Financing - April 10, 2026
Isofol receives gross proceeds of SEK 18.9 million
The exercise period for warrants of series TO1 in Isofol ended on 30 March 2026 and the outcome shows that a total of 37,301,067 TO1 were exercised for subscription of 37,301,067 new shares, corresponding to a subscription rate of approximately 93.57 per cent.
Biotech Business - March 25, 2026
Tenboron receives EUR 7.6 million EU funding
Tenboron has received a positive funding decision from the European Union Horizon Europe Health 2025 programme for Phase 1 and 2 clinical studies of its TB0010 boron carrier for Boron Neutron Capture Therapy (BNCT).
